These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7482309)

  • 1. [A trial of the use of sandostatin in patients with chronic pancreatitis].
    Loginov AS; Sadokov VM; Vinokurova LV; Chernoiarova OD; Astaf'eva OV; Nilova TV
    Ter Arkh; 1995; 67(7):60-2. PubMed ID: 7482309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sandostatin efficiency in the enzymatic phase of acute pancreatitis].
    Tolstoĭ AD
    Khirurgiia (Mosk); 2001; (12):58-61. PubMed ID: 11810945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sandostatin treatment of destructive pancreatitis].
    Ivanov IuV
    Klin Med (Mosk); 1999; 77(9):37-9. PubMed ID: 10599225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repetitive acute pancreatitis in a late-diagnosed cystic fibrosis: prevention of relapses by octreotide in the long term].
    Weber A; Queneau PE; Polio JC; Koch S; Fellmann F; Sauve G; Carayon P
    Gastroenterol Clin Biol; 2001 May; 25(5):546-8. PubMed ID: 11521109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sandostatin on the functional status of the pancreas in patients with chronic pancreatitis].
    Astaf'eva OV; Vinokurova LV; Banifatov PV
    Eksp Klin Gastroenterol; 2002; (6):42-3, 112. PubMed ID: 12685011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis].
    Bagnenko SF; Rukhliada NV; Tolstoĭ AD; Gol'tsov VR; Nazarov VE
    Vestn Khir Im I I Grek; 2002; 161(6):26-9. PubMed ID: 12638487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis?
    Nikou GC; Giamarellos-Bourboulis EJ; Toumpanakis C; Arnaoutis TP; Kitsou E; Kyriaki D; Katsilambros N
    Hepatogastroenterology; 2002; 49(45):706-8. PubMed ID: 12063974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzyme preparations in conservative treatment of chronic pancreatitis].
    Okhlobystin AV; Bayarmaa N
    Ter Arkh; 1998; 70(10):86-8. PubMed ID: 9864814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delayed administration of octreotide in acute experimental pancreatitis.
    Kaplan O; Kaplan D; Casif E; Siegal A; Paran H; Graf E; Skornick Y
    J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of octreotide on pancreatic damage in TNBS-induced colitis.
    Akgül S; Erbil Y; Giris M; Alis H; Yanik BT; Olgaç V; Toker GA
    Surg Innov; 2006 Jun; 13(2):102-8. PubMed ID: 17012150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect.
    Saif MW; Larson H; Kaley K; Shaib W
    Expert Opin Drug Saf; 2010 Nov; 9(6):867-73. PubMed ID: 20662741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of pancreatic substitutes on fecal and serum elastase and on pain in patients with chronic pancreatitis].
    Aleryani S; Duris I; Payer J; Huorka M; Tesar T; Kratochvíĺová H; Ondrejka P
    Vnitr Lek; 2000 May; 46(5):263-7. PubMed ID: 11227180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sandostatin in the management of nonendocrine gastrointestinal and pancreatic disorders: a preliminary study.
    Rosenberg L; Brown RA
    Can J Surg; 1991 Jun; 34(3):223-9. PubMed ID: 2054754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapeutic applications of octreotide].
    Carrera-Hueso FJ; Carrera-Hueso JA; Llorente I
    Med Clin (Barc); 1996 Apr; 106(13):505-16. PubMed ID: 8992134
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of postoperative pancreatitis, in patients undergoing cholecystectomy for cholelithiasis].
    Vakhrushev IaM; Kropacheva NS
    Eksp Klin Gastroenterol; 2010; (8):42-5. PubMed ID: 21268325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of Sandostatin in the combined treatment of acute destructive pancreatitis].
    Lysenko MV; Meshkov VV; Ursov SV; Kuznetsova IV; Nikiforova DM
    Voen Med Zh; 1997 Jan; 318(1):68-70. PubMed ID: 9254475
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E; Baser M; Aydin M; Guler O
    Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.